TrialHaematologica2013

Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trial.

Nicolas Mounier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.